GPP
PHVS icon

Great Point Partners’s Pharvaris PHVS Stock Holding History

Great Point Partners’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-82,800
Closed -$2.34M – 51
2026
Q1 		$2.34M Hold
82,800
– – 0.54% 36
2025
Q4 		$2.3M Sell
82,800
-72,305
-47% -$1.74M 0.75% 27
2025
Q3 		$3.87M Buy
+155,105
New +$3.44M 1.6% 21

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Great Point Partners's PHVS Position: Q2 2026 in Review

Great Point Partners sold out of Pharvaris (PHVS) in Q2 2026, closing a stake of 82,800 shares — an estimated $2.34M sold.

Great Point Partners first reported a position in PHVS in Q3 2025 and held it in 3 quarters. The position peaked at $3.87M in Q3 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Great Point Partners reported no remaining Pharvaris position as of Q2 2026 after selling out during the quarter.
  • Great Point Partners sold 82,800 Pharvaris shares in Q2 2026, an estimated $2.34M.
  • Great Point Partners first reported a position in Pharvaris in Q3 2025 and held it in 3 quarters.
  • Great Point Partners's Pharvaris position peaked at $3.87M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Great Point Partners's 13F filing for Q2 2026, filed 14 Aug 2026.